Octimibate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOctimibate
Drug Alias NameNAT-04-152
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstacyclin agonistsAcyl coenzyme A:cholesterol acyltransferase inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferaseProstacyclin
Therapy Area/IndicationsThrombosisAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsThrombosisAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A